Literature DB >> 31462079

The vicious cycle between transglutaminase 2 and reactive oxygen species in hyperglycemic memory-induced endothelial dysfunction.

Jee-Yeon Lee1, Yeon-Ju Lee1, Hye-Yoon Jeon1, Eun-Taek Han2, Won Sun Park3, Seok-Ho Hong4, Young-Myeong Kim1, Kwon-Soo Ha1.   

Abstract

Clinical trials suggested that the vascular system can remember episodes of poor glycemic control through a phenomenon known as hyperglycemic memory (HGM). HGM is associated with long-term diabetic vascular complications in type 1 and type 2 diabetes, although the molecular mechanism of that association is not clearly understood. We hypothesized that transglutaminase 2 (TGase2) and intracellular reactive oxygen species (ROS) play a key role in HGM-induced vascular dysfunction. We found that hyperglycemia induced persistent oxidative stress, expression of inflammatory adhesion molecules, and apoptosis in the aortic endothelium of HGM mice whose blood glucose levels had been normalized by insulin supplementation. TGase2 activation and ROS generation were in a vicious cycle in the aortic endothelium of HGM mice and also in human aortic endothelial cells after glucose normalization, which played a key role in the sustained expression of inflammatory adhesion molecules and apoptosis. Our findings suggest that the TGase2-ROS vicious cycle plays an important role in HGM-induced endothelial dysfunction.-Lee, J.-Y., Lee, Y.-J., Jeon, H.-Y., Han, E.-T., Park, W. S., Hong, S.-H., Kim, Y.-M., Ha, K.-S. The vicious cycle between transglutaminase 2 and reactive oxygen species in hyperglycemic memory-induced endothelial dysfunction.

Entities:  

Keywords:  ROS; TGase2; apoptosis; diabetes mellitus; inflammation

Mesh:

Substances:

Year:  2019        PMID: 31462079      PMCID: PMC6902669          DOI: 10.1096/fj.201901358RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  37 in total

Review 1.  The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes.

Authors:  P King; I Peacock; R Donnelly
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

2.  Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells.

Authors:  Jun Okabe; Christian Orlowski; Aneta Balcerczyk; Chris Tikellis; Merlin C Thomas; Mark E Cooper; Assam El-Osta
Journal:  Circ Res       Date:  2012-03-08       Impact factor: 17.367

Review 3.  The function of tissue transglutaminase in celiac disease.

Authors:  Antonio Di Sabatino; Alessandro Vanoli; Paolo Giuffrida; Ombretta Luinetti; Enrico Solcia; Gino Roberto Corazza
Journal:  Autoimmun Rev       Date:  2012-02-03       Impact factor: 9.754

4.  Transglutaminase 2 gene ablation protects against renal ischemic injury by blocking constant NF-κB activation.

Authors:  Dae-Seok Kim; Bora Kim; Hongmin Tahk; Dong-Hyun Kim; Eu-Ree Ahn; Changsun Choi; Yoon Jeon; Seo Young Park; Ho Lee; Seung Hyun Oh; Soo-Youl Kim
Journal:  Biochem Biophys Res Commun       Date:  2010-11-19       Impact factor: 3.575

5.  Cysteamine prevents vascular leakage through inhibiting transglutaminase in diabetic retina.

Authors:  Yeon-Ju Lee; Se-Hui Jung; JongYun Hwang; Sohee Jeon; Eun-Taek Han; Won Sun Park; Seok-Ho Hong; Young-Myeong Kim; Kwon-Soo Ha
Journal:  J Endocrinol       Date:  2017-07-27       Impact factor: 4.286

6.  Proinsulin C-peptide prevents hyperglycemia-induced vascular leakage and metastasis of melanoma cells in the lungs of diabetic mice.

Authors:  Hye-Yoon Jeon; Yeon-Ju Lee; You-Sun Kim; Soo-Youl Kim; Eun-Taek Han; Won Sun Park; Seok-Ho Hong; Young-Myeong Kim; Kwon-Soo Ha
Journal:  FASEB J       Date:  2018-07-18       Impact factor: 5.191

7.  Long-term follow-up after tight control of blood pressure in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; H Andrew W Neil; David R Matthews
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

Review 8.  Bax, reactive oxygen, and cytochrome c release in neuronal apoptosis.

Authors:  Rebecca A Kirkland; James L Franklin
Journal:  Antioxid Redox Signal       Date:  2003-10       Impact factor: 8.401

9.  Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail.

Authors:  Daniella Brasacchio; Jun Okabe; Christos Tikellis; Aneta Balcerczyk; Prince George; Emma K Baker; Anna C Calkin; Michael Brownlee; Mark E Cooper; Assam El-Osta
Journal:  Diabetes       Date:  2009-02-10       Impact factor: 9.461

10.  C-peptide activates AMPKα and prevents ROS-mediated mitochondrial fission and endothelial apoptosis in diabetes.

Authors:  Mahendra Prasad Bhatt; Young-Cheol Lim; Young-Myeong Kim; Kwon-Soo Ha
Journal:  Diabetes       Date:  2013-07-24       Impact factor: 9.461

View more
  6 in total

Review 1.  Hyperglycemic memory in diabetic cardiomyopathy.

Authors:  Jiabing Zhan; Chen Chen; Dao Wen Wang; Huaping Li
Journal:  Front Med       Date:  2021-12-18       Impact factor: 4.592

2.  Apelin/APJ relieve diabetic cardiomyopathy by reducing microvascular dysfunction.

Authors:  Bin Li; Jiming Yin; Jing Chang; Jia Zhang; Yangjia Wang; Haixia Huang; Wei Wang; Xiangjun Zeng
Journal:  J Endocrinol       Date:  2021-04       Impact factor: 4.286

3.  KDM3A Inhibition Ameliorates Hyperglycemia-Mediated Myocardial Injury by Epigenetic Modulation of Nuclear Factor Kappa-B/P65.

Authors:  Bofang Zhang; Jing Zhang; Gen Liu; Xin Guo; Xiaopei Liu; Jing Chen
Journal:  Front Cardiovasc Med       Date:  2022-04-29

4.  Molecular hydrogen improves type 2 diabetes through inhibiting oxidative stress.

Authors:  Yi Ming; Qi-Hang Ma; Xin-Li Han; Hong-Yan Li
Journal:  Exp Ther Med       Date:  2020-04-30       Impact factor: 2.447

5.  Overexpression of MicroRNA-122 Resists Oxidative Stress-Induced Human Umbilical Vascular Endothelial Cell Injury by Inhibition of p53.

Authors:  Hua-Qing Li; Zhi-Yu Pan; Zhen Yang; Don-Bing Zhang; Qian Chen
Journal:  Biomed Res Int       Date:  2020-10-27       Impact factor: 3.411

6.  Midazolam Ameliorates Hyperglycemia-Induced Glomerular Endothelial Dysfunction by Inhibiting Transglutaminase 2 in Diabetes.

Authors:  Jae-Ah Seo; Nilofar Danishmalik Sayyed; Yeon-Ju Lee; Hye-Yoon Jeon; Eun-Bin Kim; Seok-Ho Hong; Soyeon Cho; Minsoo Kim; Kwon-Soo Ha
Journal:  Int J Mol Sci       Date:  2022-01-11       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.